Recombinant B7-H3 (Enoblituzumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7766377

The Humanized Monoclonal anti-B7-H3 (Enoblituzumab Biosimilar) antibody has been validated for ELISA, FACS and CyTox. It is suitable to detect B7-H3 (Enoblituzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant B7-H3 (Enoblituzumab Biosimilar) antibody (Biotin) (ABIN7766377)

Target: B7-H3 (Enoblituzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This B7-H3 (Enoblituzumab Biosimilar) antibody is conjugated to Biotin

Application: ELISA, Flow Cytometry (FACS), Cytotoxicity Test (CyTox)

Product Details anti-B7-H3 (Enoblituzumab Biosimilar) Antibody (Biotin)

Purpose: Conjugated Anti-B7-H3 (enoblituzumab biosimilar) mAb

Purification: Purified from cell culture supernatant by affinity chromatography

Application Details

Application Notes: working with enzyme-conjugated streptavidin, most applications: 1: 50 - 1: 1,000

Restrictions: For Research Use only

Handling

Buffer: Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Protect from light!

Storage: 4 °C

Storage Comment: Store at 4°C in dark for 6 months

Target Details for B7-H3 (Enoblituzumab Biosimilar)

Target: B7-H3 (Enoblituzumab Biosimilar)

Alternative Name: enoblituzumab biosimilar

Target Type: Biosimilar

Background: B7-H3, CD276, B7 homolog 3